Lexicon Pharmaceuticals Inc Sustainability Reports
Lexicon Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of pharmaceutical products. Its portfolio includes pipeline treatments targeting heart failure, neuropathic pain, and metabolic disorders.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG001SDWCZ8
4 reports from 2016 to 2023
Company Profile
Lexicon Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of pharmaceutical products. Its portfolio includes pipeline treatments targeting heart failure, neuropathic pain, and metabolic disorders.
Reports
4 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
